Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Monika Herian & Paweł Świt. (2023) 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review. Critical Reviews in Toxicology 53:1, pages 15-33.
Read now
Read now
Kyung Sik Yoon, Sun Mi Gu, Hye Jin Cha, Young-Hoon Kim, Jaesuk Yun & Jin-Moo Lee. (2022) 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1. Drug and Chemical Toxicology 45:2, pages 898-906.
Read now
Read now
Maren Hermanns-Clausen, Verena Angerer, Josephine Kithinji, Christina Grumann & Volker Auwärter. (2017) Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus. Clinical Toxicology 55:8, pages 922-924.
Read now
Read now
Paul Gee, Leo J. Schep, Berit P. Jensen, Grant Moore & Stuart Barrington. (2016) Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases. Clinical Toxicology 54:2, pages 141-146.
Read now
Read now
Benny J. Lum, Joseph J. Brophy & D. Brynn Hibbert. (2016) Identification of 4-substituted 2-(4-x-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25X-NBOMe) and analogues by gas chromatography–mass spectrometry analysis of heptafluorobutyric anhydride (HFBA) derivatives. Australian Journal of Forensic Sciences 48:1, pages 59-73.
Read now
Read now
David M. Wood, Roumen Sedefov, Andrew Cunningham & Paul I. Dargan. (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology 53:2, pages 85-92.
Read now
Read now
Panagiota Nikolaou, Ioannis Papoutsis, Maria Stefanidou, Chara Spiliopoulou & Sotiris Athanaselis. (2015) 2C-I-NBOMe, an “N-bomb” that kills with “Smiles”. Toxicological and legislative aspects. Drug and Chemical Toxicology 38:1, pages 113-119.
Read now
Read now
Joji Suzuki, Justin L. Poklis & Alphonse Poklis. (2014) “My Friend Said it was Good LSD”: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion. Journal of Psychoactive Drugs 46:5, pages 379-382.
Read now
Read now
Mathias B. Forrester. (2014) NBOMe Designer Drug Exposures Reported to Texas Poison Centers. Journal of Addictive Diseases 33:3, pages 196-201.
Read now
Read now
M. H. Y. Tang, C. K. Ching, M. S. H. Tsui, F. K. C. Chu & T. W. L. Mak. (2014) Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clinical Toxicology 52:5, pages 561-565.
Read now
Read now
Simon L. Hill, Tom Doris, Shiv Gurung, Stephen Katebe, Alexander Lomas, Mick Dunn, Peter Blain & Simon H. L. Thomas. (2013) Severe clinical toxicity associated with analytically confirmed recreational use of 25I–NBOMe: case series. Clinical Toxicology 51:6, pages 487-492.
Read now
Read now
Articles from other publishers (89)
Marie H. Deventer, Mattias Persson, Antonio Laus, Eline Pottie, Annelies Cannaert, Graziella Tocco, Henrik Gréen & Christophe P. Stove. (2023) Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor. Archives of Toxicology 97:5, pages 1367-1384.
Crossref
Crossref
Hyun-A. Oh, Jae Hong Yoo, Ye-Ji Kim, Kyung-Seok Han & Dong Ho Woo. (2023) 4-EA-NBOMe, an amphetamine derivative, alters glutamatergic synaptic transmission through 5-HT1A receptors on cortical neurons from Sprague Dawley rat and pyramidal neurons from C57BL/6 mouse. NeuroToxicology 95, pages 144-154.
Crossref
Crossref
Maria Nieddu, Elena Baralla, Federica Sodano & Gianpiero Boatto. (2022) Analysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review. Forensic Toxicology 41:1, pages 1-24.
Crossref
Crossref
William Feeney, Arun S. Moorthy & Edward Sisco. (2022) Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds. Forensic Chemistry 31, pages 100459.
Crossref
Crossref
Kyung Sik Yoon, Hye Jin Cha, Sun Ok Choi & Jin-Moo Lee. (2022) 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system. Toxicology Letters 355, pages 160-169.
Crossref
Crossref
Carlos Alberto Yasin Wayhs, Caroline Tortato, Kristiane De Cássia Mariotti, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2021) New Psychoactive Substances Constant State of Flux: NBOMe Brazilian Case. Brazilian Journal of Forensic Sciences, Medical Law and Bioethics 11:1, pages 62-69.
Crossref
Crossref
Emil Märcher Rørsted, Anders A. Jensen & Jesper L. Kristensen. (2021) 25CN‐NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor. ChemMedChem 16:21, pages 3263-3270.
Crossref
Crossref
Jan-Niklas Kleis, Cornelius Hess, Tanja Germerott & Joerg Roehrich. (2021) Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology.
Crossref
Crossref
Katarzyna Kamińska, Paweł Świt & Kamilla Malek. (2020)
2-(4-Iodo-2,5-dimethoxyphenyl)-
N
-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review
. Journal of Analytical Toxicology 44:9, pages 947-956.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Crossref
Bruna de Souza Boff, Jair Silveira Filho, Karina Nonemacher, Samilla Driessen Schroeder, Marcelo Dutra Arbo & Kéttulin Zomer Rezin. (2020) New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study. Forensic Science International 306, pages 110002.
Crossref
Crossref
Lilian H. J. Richter, Julia Menges, Lea Wagmann, Simon D. Brandt, Alexander Stratford, Folker Westphal, Veit Flockerzi & Markus R. Meyer. (2019) In vitro toxicokinetics and analytical toxicology of three novel NBOMe derivatives: phase I and II metabolism, plasma protein binding, and detectability in standard urine screening approaches studied by means of hyphenated mass spectrometry. Forensic Toxicology 38:1, pages 141-159.
Crossref
Crossref
Cristina Miliano, Matteo Marti, Nicholas Pintori, Maria Paola Castelli, Micaela Tirri, Raffaella Arfè & Maria Antonietta De Luca. (2019) Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. Frontiers in Pharmacology 10.
Crossref
Crossref
Camila M. de Almeida, Fernanda E. Pinto, Nayara A. dos Santos, Lindamara M. de Souza, Bianca B. Merlo, Christopher J. Thompson & Wanderson Romão. (2019) Designer drugs analysis by LDI(+), MALDI(+) and MALDI(+) imaging coupled to FT-ICR MS. Microchemical Journal 149, pages 104002.
Crossref
Crossref
Yoshimi Peck, Alan R. Clough, Peter N. Culshaw & Michael J. Liddell. (2019) Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia. Drug and Alcohol Dependence 201, pages 49-57.
Crossref
Crossref
Monika Herian, Adam Wojtas, Katarzyna Kamińska, Paweł Świt, Anna Wach & Krystyna Gołembiowska. (2019) Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats. Neurotoxicity Research 36:1, pages 91-100.
Crossref
Crossref
Ana Maria dos Santos Moreira, Hanna Leijoto de Oliveira, João Francisco Allochio Filho, Diego Hernando Ângulo Florez, Marcela Matos Cordeiro Borges, Valdemar LacerdaJr.Jr., Wanderson Romão & Keyller Bastos Borges. (2019) NBOMe compounds: An overview about analytical methodologies aiming their determination in biological matrices. TrAC Trends in Analytical Chemistry 114, pages 260-277.
Crossref
Crossref
Kyung Sik Yoon, Jaesuk Yun, Young-Hoon Kim, Jisoon Shin, Sung Jin Kim, Jung-Wook Seo, Sung-Ae Hyun, Soo Kyung Suh & Hye Jin Cha. (2019) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo. Toxicology Letters 304, pages 50-57.
Crossref
Crossref
Nino Cesar Marchi, Juliana Nichterwitz Scherer, Letícia Schwanck Fara, Lysa Remy, Rafaela Ornel, Monique Reis, Amanda Zamboni, Mariana Paim, Taís Regina Fiorentin, Carlos Alberto Yasin Wayhs, Lisia Von Diemen, Flavio Pechansky, Felix Henrique Paim Kessler & Renata Pereira Limberger. (2019) Clinical and Toxicological Profile of NBOMes: A Systematic Review. Psychosomatics 60:2, pages 129-138.
Crossref
Crossref
Kelly Francisco da Cunha, Marcos Nogueira Eberlin, Marilyn A. Huestis & José Luiz Costa. (2018) NBOMe instability in whole blood. Forensic Toxicology 37:1, pages 82-89.
Crossref
Crossref
David J. Heal, Jane Gosden & Sharon L. Smith. (2018) Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology 142, pages 89-115.
Crossref
Crossref
Achim T. Caspar, Markus R. Meyer, Folker Westphal, Armin A. Weber & Hans H. Maurer. (2018) Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine. Talanta 188, pages 111-123.
Crossref
Crossref
Dino Luethi, Daniel Trachsel, Marius C. Hoener & Matthias E. Liechti. (2018) Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs). Neuropharmacology 134, pages 141-148.
Crossref
Crossref
Achim T. Caspar, Markus R. Meyer & Hans H. Maurer. (2018) Human cytochrome P450 kinetic studies on six N -2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approach. Toxicology Letters 285, pages 1-8.
Crossref
Crossref
Laura Hondebrink, Anne Zwartsen & Remco H.S. Westerink. (2018) Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?. Pharmacology & Therapeutics 182, pages 193-224.
Crossref
Crossref
Ahmed Al-Imam. (2018) 25b-NBOMe: A Case Report of Sudden Death and Insightful View of Google Trends Data. Iranian Journal of Psychiatry and Behavioral Sciences 12:1.
Crossref
Crossref
Achim T. Caspar, Andreas B. Kollas, Hans H. Maurer & Markus R. Meyer. (2018) Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry. Talanta 176, pages 635-645.
Crossref
Crossref
Kelly Francisco da Cunha, Marcos Nogueira Eberlin & Jose Luiz Costa. (2017) Development and validation of a sensitive LC–MS/MS method to analyze NBOMes in dried blood spots: evaluation of long-term stability. Forensic Toxicology 36:1, pages 113-121.
Crossref
Crossref
Sabrina Lehmann, Tobias Kieliba, Justus Beike, Mario Thevis & Katja Mercer-Chalmers-Bender. (2017) Determination of 74 new psychoactive substances in serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 1064, pages 124-138.
Crossref
Crossref
Daniel Pasin, Adam Cawley, Sergei Bidny & Shanlin Fu. (2017) Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes. Drug Testing and Analysis 9:10, pages 1620-1629.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
Keith-Dane H. Temporal, Karen S. Scott, Amanda L.A. Mohr & Barry K. Logan. (2017) Metabolic Profile Determination of NBOMe Compounds Using Human Liver Microsomes and Comparison with Findings in Authentic Human Blood and Urine. Journal of Analytical Toxicology 41:7, pages 646-657.
Crossref
Crossref
James J. LynchIIIIII, Terry R. Van Vleet, Scott W. Mittelstadt & Eric A.G. Blomme. (2017) Potential functional and pathological side effects related to off-target pharmacological activity. Journal of Pharmacological and Toxicological Methods 87, pages 108-126.
Crossref
Crossref
Érica Naomi Oiye, Juliana Midori Toia Katayama, Maria Fernanda Muzetti Ribeiro & Marcelo Firmino de Oliveira. (2017) Electrochemical analysis of 25H-NBOMe by Square Wave Voltammetry. Forensic Chemistry 5, pages 86-90.
Crossref
Crossref
Ritva Karinen & Gudrun Høiseth. (2017) A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylamines. Forensic Science International 276, pages 120-125.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
Ariane Wohlfarth, Markus Roman, Mikael Andersson, Fredrik C. Kugelberg, Xingxing Diao, Jeremy Carlier, Caroline Eriksson, Xiongyu Wu, Peter Konradsson, Martin Josefsson, Marilyn A. Huestis & Robert Kronstrand. (2017)
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes,
in vivo
mouse and human urine with high-resolution mass spectrometry
. Drug Testing and Analysis 9:5, pages 680-698.
Crossref
Crossref
Ana Flávia B. AndradeSamuel Kasahun MamoJose Gonzalez-Rodriguez. (2017) Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry. Analytical Chemistry 89:3, pages 1445-1452.
Crossref
Crossref
Camille Richeval, Alexandra Boucher, Luc Humbert, Mélodie Phanithavong, Jean-François Wiart, Mustapha Moulsma, Antony Citterio-Quentin, Thierry Coulon, Romain Hernu, Thierry Vial, Delphine Allorge & Jean-Michel Gaulier. (2017) Retrospective identification of 25I-NBOMe metabolites in an intoxication case. Toxicologie Analytique et Clinique 29:1, pages 71-81.
Crossref
Crossref
Sandra Bodeau, Youssef Bennis, Océane Régnaut, Nicolas Fabresse, Camille Richeval, Luc Humbert, Jean-Claude Alvarez, Delphine Allorge & Anne-Sophie Lemaire-Hurtel. (2017) LSD instead of 25I-NBOMe: The revival of LSD? A case report. Toxicologie Analytique et Clinique 29:1, pages 139-143.
Crossref
Crossref
Alice Ameline, Pascal Kintz, Caroline Blettner, Éric Bayle & Jean-Sébastien Raul. (2017) Identification of 25I-NBOMe in two intoxications cases with severe hallucinations. Toxicologie Analytique et Clinique 29:1, pages 117-122.
Crossref
Crossref
Marek Wiergowski, Justyna Aszyk, Michał Kaliszan, Kamila Wilczewska, Jacek Sein Anand, Agata Kot-Wasik & Zbigniew Jankowski. (2017) Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC–MS/MS in case of severe intoxications. Journal of Chromatography B 1041-1042, pages 1-10.
Crossref
Crossref
Christine Murphy & George Sam Wang. 2017. Case Studies in Medical Toxicology. Case Studies in Medical Toxicology
79
88
.
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
283
311
.
Carlos Alberto Yasin Wayhs, Monique dos Reis, Kristiane de Cássia Mariotti, Wanderson Romão, Boniek Gontijo Vaz, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2016) NBOMe: perfil de apreensões da Polícia Federal no Brasil. Revista Brasileira de Criminalística 5:3, pages 22-29.
Crossref
Crossref
Sabra Botch-Jones, Jamie Foss, David Barajas, Frank Kero, Craig Young & Jason Weisenseel. (2016) The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography. Forensic Science International 267, pages 89-95.
Crossref
Crossref
Boris Duffau, Cristian Camargo, Marcelo Kogan, Edwar Fuentes & Bruce Kennedy Cassels. (2016) Analysis of 25 C NBOMe in Seized Blotters by HPTLC and GC–MS. Journal of Chromatographic Science 54:7, pages 1153-1158.
Crossref
Crossref
Samantha J. Coward & Hilary J. Hamnett. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
127
146
.
John J. Kristofic, Jeffrey D. Chmiel, George F. Jackson, Shawn P. Vorce, Justin M. Holler, Stephen L. Robinson & Thomas Z. Bosy. (2016) Detection of 25C-NBOMe in Three Related Cases. Journal of Analytical Toxicology 40:6, pages 466-472.
Crossref
Crossref
David E. Nichols. (2016) Psychedelics. Pharmacological Reviews 68:2, pages 264-355.
Crossref
Crossref
Elli Tyrkkö, Mikael Andersson & Robert Kronstrand. (2016) The Toxicology of New Psychoactive Substances. Therapeutic Drug Monitoring 38:2, pages 190-216.
Crossref
Crossref
Adam Cawley, Daniel Pasin, Namuun Ganbat, Laura Ennis, Corrine Smart, Candace Greer, John Keledjian, Shanlin Fu & Alex Chen. (2016) The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry. Analytical Methods 8:8, pages 1789-1797.
Crossref
Crossref
Dariusz Zuba, Piotr Adamowicz & Simon Elliott. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
935
944
.
Marcelo Dutra Arbo, Rachel Picada Bulcão, Luciana Grazziotin Rossato, Elza Callegari, Lucas Henrique Cendron, Eduardo Rodrigues Cabrera, Marco Antonio de Freitas & Mirna Bainy Leal. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
50
60
.
Piotr Adamowicz, Joanna Gieroń, Dominika Gil, Wojciech Lechowicz, Agnieszka Skulska & Bogdan Tokarczyk. (2016) The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland. Drug Testing and Analysis 8:1, pages 63-70.
Crossref
Crossref
Michael F Weaver, John A Hopper & Erik W Gunderson. (2015) Designer drugs 2015: assessment and management. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
M.A. Hieger, S.R. Rose, K.L. Cumpston, P.E. Stromberg, S. Miller & B.K. Wills. (2015) Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series. The American Journal of Emergency Medicine 33:12, pages 1843.e1-1843.e3.
Crossref
Crossref
Sara Andrabi, Spencer Greene, Nidal Moukaddam & Benjamin Li. (2015) New Drugs of Abuse and Withdrawal Syndromes. Emergency Medicine Clinics of North America 33:4, pages 779-795.
Crossref
Crossref
Lyndsey M. Lowe, Brianna L. Peterson & Fiona J. Couper. (2015) A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State. Journal of Analytical Toxicology 39:8, pages 668-671.
Crossref
Crossref
Justin L. Poklis, Sara K. Dempsey, Kai Liu, Joseph K. Ritter, Carl Wolf, Shijun Zhang & Alphonse Poklis. (2015) Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication. Journal of Analytical Toxicology 39:8, pages 607-616.
Crossref
Crossref
Justin L. Poklis, Stephen A. Raso, Kylie N. Alford, Alphonse Poklis & Michelle R. Peace. (2015)
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-
N
-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
. Journal of Analytical Toxicology 39:8, pages 617-623.
Crossref
Crossref
Kevin G. Shanks, Thomas Sozio & George S. Behonick. (2015) Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014. Journal of Analytical Toxicology 39:8, pages 602-606.
Crossref
Crossref
Geoffrey K Isbister, Alphonse Poklis, Justin L Poklis & Jeffrey Grice. (2015) Beware of blotting paper hallucinogens: severe toxicity with NBOMes. Medical Journal of Australia 203:6, pages 266-267.
Crossref
Crossref
Achim T. Caspar, Andreas G. Helfer, Julian A. Michely, Volker Auw?rter, Simon D. Brandt, Markus R. Meyer & Hans H. Maurer. (2015) Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS. Analytical and Bioanalytical Chemistry 407:22, pages 6697-6719.
Crossref
Crossref
Brenda Wasunna, Emily Thomas & Sally Morgan. (2015) Development of legal highs. Journal of Psychiatric Intensive Care 11:02, pages 128-137.
Crossref
Crossref
José Coelho Neto. (2015) Rapid detection of NBOME's and other NPS on blotter papers by direct ATR-FTIR spectrometry. Forensic Science International 252, pages 87-92.
Crossref
Crossref
Mette Findal Andreasen, Rasmus Telving, Ingrid Rosendal, Marlene Beyer Eg, Jørgen Bo Hasselstrøm & Ljubica Vukelic Andersen. (2015) A fatal poisoning involving 25C-NBOMe. Forensic Science International 251, pages e1-e8.
Crossref
Crossref
Victoria B. Kueppers & Clive T. Cooke. (2015) 25I-NBOMe related death in Australia: A case report. Forensic Science International 249, pages e15-e18.
Crossref
Crossref
Yoshie Umemura, Thomas A. Andrew, Valerie L. Jacobs, Andrew J. Giustini, Lionel D. Lewis & James J. Filiano. (2015) Fatal 25I-NBOMe Intoxication: A New Recreational Risk. Academic Forensic Pathology 5:1, pages 91-97.
Crossref
Crossref
Joji Suzuki, Michael A. Dekker, Erin S. Valenti, Fabiola A. Arbelo Cruz, Ady M. Correa, Justin L. Poklis & Alphonse Poklis. (2015) Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature. Psychosomatics 56:2, pages 129-139.
Crossref
Crossref
Elaine Perry, Urs Peter Mosimann & Daniel Collerton. 2015. The Neuroscience of Visual Hallucinations. The Neuroscience of Visual Hallucinations
321
341
.
Patil Armenian & Roy R. Gerona. (2014) The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. The American Journal of Emergency Medicine 32:11, pages 1444.e3-1444.e5.
Crossref
Crossref
Robert D. Johnson, Sabra R. Botch-Jones, Tiffany Flowers & Connie A. Lewis. (2014) An Evaluation of 25B-, 25C-, 25D-, 25H-, 25I- and 25T2-NBOMe via LC–MS-MS: Method Validation and Analyte Stability. Journal of Analytical Toxicology 38:8, pages 479-484.
Crossref
Crossref
Will Lawn, Monica Barratt, Martin Williams, Abi Horne & Adam Winstock. (2014) The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology 28:8, pages 780-788.
Crossref
Crossref
Megan E. Musselman & Jeremy P. Hampton. (2014)
“
Not for Human Consumption”: A Review of Emerging Designer Drugs
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:7, pages 745-757.
Crossref
Crossref
L. A. King. (2014) New phenethylamines in Europe. Drug Testing and Analysis 6:7-8, pages 808-818.
Crossref
Crossref
Justin L. Poklis, Carol R. Nanco, Michelle M. Troendle, Carl E. Wolf & Alphonse Poklis. (2014) Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Testing and Analysis 6:7-8, pages 764-769.
Crossref
Crossref
Monica J. Barratt, Jason A. Ferris & Adam R. Winstock. (2014) Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction 109:5, pages 774-783.
Crossref
Crossref
J. L. Poklis, D. J. Clay & A. Poklis. (2014) High-Performance Liquid Chromatography with Tandem Mass Spectrometry for the Determination of Nine Hallucinogenic 25-NBOMe Designer Drugs in Urine Specimens. Journal of Analytical Toxicology 38:3, pages 113-121.
Crossref
Crossref
Jeffrey P. Walterscheid, Garrett T. Phillips, Ana E. Lopez, Morna L. Gonsoulin, Hsin-Hung Chen & Luis A. Sanchez. (2014) Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity. American Journal of Forensic Medicine & Pathology 35:1, pages 20-25.
Crossref
Crossref
Samuel J. Stellpflug, Samantha E. Kealey, Cullen B. Hegarty & Gregory C. Janis. (2013) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): Clinical Case with Unique Confirmatory Testing. Journal of Medical Toxicology 10:1, pages 45-50.
Crossref
Crossref
Adam L. Halberstadt & Mark A. Geyer. (2014) Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology 77, pages 200-207.
Crossref
Crossref
Justin L. Poklis, Kelly G. Devers, Elise F. Arbefeville, Julia M. Pearson, Eric Houston & Alphonse Poklis. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Science International 234, pages e14-e20.
Crossref
Crossref
Kathryn A. Seely, Amy L. Patton, Cindy L. Moran, Mary L. Womack, Paul L. Prather, William E. Fantegrossi, Anna Radominska-Pandya, Gregory W. Endres, Kermit B. Channell, Nathaniel H. Smith, Keith R. McCain, Laura P. James & Jeffery H. Moran. (2013) Forensic investigation of K2, Spice, and ?bath salt? commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds. Forensic Science International 233:1-3, pages 416-422.
Crossref
Crossref
Justin L. Poklis, Jezelle Charles, Carl E. Wolf & Alphonse Poklis. (2013) High‐performance liquid chromatography tandem mass spectrometry method for the determination of 2CC‐NBOMe and 25I‐NBOMe in human serum. Biomedical Chromatography 27:12, pages 1794-1800.
Crossref
Crossref
Robert Haberzettl, Bettina Bert, Heidrun Fink & Meredith A. Fox. (2013) Animal models of the serotonin syndrome: A systematic review. Behavioural Brain Research 256, pages 328-345.
Crossref
Crossref